Victory Capital Management’s TELA Bio TELA Stock Holding History

Victory Capital Management’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-711	Closed	-$6K	–	3214
2020 Q1	$6K	Buy	+711	New	+$9.6K	﹤0.01%	3244

Other funds holding TELA

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Victory Capital Management's TELA Position: Q2 2020 in Review

Victory Capital Management sold out of TELA Bio (TELA) in Q2 2020, closing a stake of 711 shares — an estimated $6K sold.

Victory Capital Management first reported a position in TELA in Q1 2020 and held it in 1 quarter. The position peaked at $6K in Q1 2020. 49 funds tracked by Wall St. Rank hold TELA as of Q2 2020.

Victory Capital Management reported no remaining TELA Bio position as of Q2 2020 after selling out during the quarter.
Victory Capital Management sold 711 TELA Bio shares in Q2 2020, an estimated $6K.
Victory Capital Management first reported a position in TELA Bio in Q1 2020 and held it in 1 quarter.
Victory Capital Management's TELA Bio position peaked at $6K in Q1 2020.
49 funds tracked by Wall St. Rank held TELA Bio as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.